N/A
N=145
The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)
Carcinoma, Hepatocellular · Chronic Hepatitis B
Bottom Line
View on ClinicalTrials.gov: NCT00397540 ↗Enrolled (actual)
145
Serious AEs
0.0%
Results posted
Mar 2010
Primary outcome: Primary: 1,3,5 Year-Disease Free Survival (or Recurrence Free Survival) — 11; 13; 25; 34 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- PEIT (Procedure); RFTA (Procedure)
- Age
- Adult, Older Adult · 19+ yrs
- Sex
- All
- Sponsor
- Seoul National University Hospital
- Primary completion
- May 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY 1,3,5 Year-Disease Free Survival (or Recurrence Free Survival) |
11; 13; 25; 34; 26; 37 | — |
| SECONDARY Overall Survival |
0; 0 | — |
Summary
The purpose of this study is to evaluate the effect of serum hepatitis B virus (HBV) DNA level on intrahepatic recurrence in locally treatable hepatocellular carcinomas (HCCs) related with HBV.
Eligibility Criteria
Inclusion Criteria
- Child-Pugh Class A or B
- Maximal tumor size less than 5 cm
- No previous history of treatment for hepatocellular carcinoma
- Recurrent hepatocellular carcinoma located more than 2 cm from the previous cancer site and is found more than 1 year's gap
Exclusion Criteria
- Hepatocellular carcinoma in portal vein
- Hepatocellular carcinoma in hepatic vein
Data sourced from ClinicalTrials.gov (NCT00397540). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.